Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis.

Luo, Lili; Luo, Ting; Du, Mengyi; Mei, Heng; Hu, Yu

Luo, Lili; Luo, Ting; Du, Mengyi; Mei, Heng; Hu, Yu.

Luo L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Luo T; Nephrology Division, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Du M; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Mei H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Electronic address: hmei@hust.edu.cn.
Hu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Electronic address: dr_huyu@126.com.

J Infect ; 84(3): 418-467, 2022 03.

Article in English | MEDLINE | ID: covidwho-1521291

Subject(s)

COVID-19 Drug Treatment; Antibodies, Monoclonal, Humanized/adverse effects; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article Affiliation country: J.jinf.2021.11.013

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google